Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.430
+0.150 (6.58%)
At close: Mar 4, 2026, 4:00 PM EST
2.425
-0.005 (-0.21%)
After-hours: Mar 4, 2026, 4:12 PM EST

Century Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
43787200300872-
Market Cap Growth
562.89%-56.72%-33.22%-65.61%--
Enterprise Value
348.75-53.6474.2333.41674.010
Last Close Price
2.431.013.325.1315.86-
PE Ratio
--0.63-1.44-2.26-5.36-
PS Ratio
3.8513.1689.6357.70--
PB Ratio
1.190.541.080.992.20-
P/TBV Ratio
1.190.491.070.981.30-
P/FCF Ratio
--0.79-1.96-18.12-6.51-
P/OCF Ratio
--0.79-2.2721.35-9.80-
EV/Sales Ratio
3.08-8.1433.216.43--
EV/EBITDA Ratio
-0.43-0.56-0.27-7.40-
EV/EBIT Ratio
-0.39-0.51-0.25-7.10-
EV/FCF Ratio
-0.49-0.73-2.02-5.03-
Debt / Equity Ratio
0.240.300.250.160.06-0.20
Debt / EBITDA Ratio
-2.00-0.39-0.35-0.39-0.27-0.41
Debt / FCF Ratio
-0.37-0.44-0.46-2.96-0.18-0.42
Net Debt / Equity Ratio
-0.51-0.87-0.68-0.88-0.500.51
Net Debt / EBITDA Ratio
4.321.120.942.132.181.04
Net Debt / FCF Ratio
0.801.271.2416.101.481.07
Asset Turnover
0.380.020.010.0100
Quick Ratio
6.031.469.6810.5814.246.25
Current Ratio
6.251.509.9210.7214.576.51
Return on Equity (ROE)
-15.68%-73.14%-56.07%-37.46%-66.13%50.35%
Return on Assets (ROA)
-12.15%-39.25%-35.08%-28.99%-34.89%-50.48%
Return on Invested Capital (ROIC)
-30.07%-88.01%-89.83%-75.11%-86.39%-285.01%
Return on Capital Employed (ROCE)
-15.20%-48.79%-36.66%-30.47%-36.75%-56.94%
Earnings Yield
-6.07%-159.41%-69.28%-44.25%-18.66%-
FCF Yield
-25.92%-127.22%-50.96%-5.52%-15.36%-
Buyback Yield / Dilution
1.12%-86.01%-0.26%-9.05%-29.32%-
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q